comprehensive -WSS

comprehensive

author：fashion 2025-08-04 03:41:49 - browse：67141

ANDREW YATES/AFP via Getty Images

WASHINGTON — A federal judge in Delaware on Friday ruled against AstraZeneca in a case challenging the constitutionality of Medicare’s new drug price negotiation program.

Colm Connolly, chief judge of the U.S. District Court of Delaware, ruled against the company on all its major arguments. He wrote that AstraZeneca had not proved that Medicare’s new drug price negotiation program jeopardizes its constitutional property rights, and that the company didn’t have standing to challenge the guidance Medicare issued to implement the program.

The case is the first of a slew of cases filed by the pharmaceutical industry and its allies to be decided at the district court level. The Delaware ruling is a blow, as several of the other cases made similar arguments about how the program violates drugmakers’ constitutional property rights.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Why Novartis is going to walk from its acquisition of MorphoSys

focus

WSS

Startup Neumora takes a novel depression drug to Phase 3

340B reform proposal comes out of Senate working group

In early work, researchers turn to CRISPR to treat Alzheimer's

Group opposing PBM reform sets lobbying record

Readout LOUD: Venture capital, Gilead, and more M&A

A public scorecard can help hold safety

focus

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

A public scorecard can help hold safety

ChatGPT in medicine: STAT answers readers' burning questions

340B reform proposal comes out of Senate working group

Heart attack and stroke risk calculators need revising

Unique patient identifier: Experts argue the benefits, pitfalls

Dobbs anniversary: the lost opportunity of abortion as health care

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Alkermes shareholders re

Padmanee Sharma of MD Anderson at center of lawsuit over credit

explore

In early work, researchers turn to CRISPR to treat Alzheimer's

STAT Virtual Event: The State of Biosimilars: What to Watch

Problems with a popular proposal to regulate AI in health care

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Medicare has a new plan to address drug shortages

Wikipedia

focus

knowledge

Wikipedia